MLchartDataset catalogue

Utidelone

Term · Oncology and biomedicine · MLC-T-ONC-017434

A genetically engineered epothilone analog with potential antineoplastic activity. Upon administration, utidelone binds to tubulin, induces microtubule polymerization and stabilizes microtubules against depolymerization, which may result in the inhibition of cell division, the induction of G2/M arrest, and apoptosis. Compared to first-generation epothilones, this agent exhibits greater safety and enhanced activity against certain multidrug-resistant (MDR) tumors.

Table 1. Record
IdentifierMLC-T-ONC-017434
FieldOncology and biomedicine
Synonymsepothilone analog UTD1
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017434",
  "term": "Utidelone",
  "field": "Oncology and biomedicine",
  "definition": "A genetically engineered epothilone analog with potential antineoplastic activity. Upon administration, utidelone binds to tubulin, induces microtubule polymerization and stabilizes microtubules against depolymerization, which may result in the inhibition of cell division, the induction of G2/M arrest, and apoptosis. Compared to first-generation epothilones, this agent exhibits greater safety and enhanced activity against certain multidrug-resistant (MDR) tumors.",
  "synonyms": [
    "epothilone analog UTD1"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/utidelone/"
}

Record 17,030 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.